🔗 Visit the ClinicalTrials.gov page for NCT01983124
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma. | Oncotarget | 2014 | 1.33 |
| 2 | BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. | Onco Targets Ther | 2015 | 0.99 |
| 3 | Melanoma Brain Metastasis: Mechanisms, Models, and Medicine. | Int J Mol Sci | 2016 | 0.75 |
| 4 | Combined vemurafenib and fotemustine in patients with BRAFV600 melanoma progressing on vemurafenib. | Oncotarget | 2016 | 0.75 |